BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 21041309)

  • 21. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.
    Letai A; Bassik MC; Walensky LD; Sorcinelli MD; Weiler S; Korsmeyer SJ
    Cancer Cell; 2002 Sep; 2(3):183-92. PubMed ID: 12242151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation.
    Vela L; Gonzalo O; Naval J; Marzo I
    J Biol Chem; 2013 Feb; 288(7):4935-46. PubMed ID: 23283967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the BH3-only protein Puma as a direct Bak activator.
    Dai H; Pang YP; Ramirez-Alvarado M; Kaufmann SH
    J Biol Chem; 2014 Jan; 289(1):89-99. PubMed ID: 24265320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways.
    Zhang L; Lopez H; George NM; Liu X; Pang X; Luo X
    Cell Death Differ; 2011 May; 18(5):864-73. PubMed ID: 21113147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
    Rajan S; Choi M; Baek K; Yoon HS
    Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct addition of BimL to mitochondria does not lead to cytochrome c release.
    Terradillos O; Montessuit S; Huang DC; Martinou JC
    FEBS Lett; 2002 Jul; 522(1-3):29-34. PubMed ID: 12095614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Puma indirectly activates Bax to cause apoptosis in the absence of Bid or Bim.
    Jabbour AM; Heraud JE; Daunt CP; Kaufmann T; Sandow J; O'Reilly LA; Callus BA; Lopez A; Strasser A; Vaux DL; Ekert PG
    Cell Death Differ; 2009 Apr; 16(4):555-63. PubMed ID: 19079139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
    Lama D; Sankararamakrishnan R
    Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry.
    Choi YB; Sandford G; Nicholas J
    PLoS Pathog; 2012; 8(6):e1002748. PubMed ID: 22685405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bcl-2 homology domain 3 (BH3)-only proteins Bim and bid are functionally active and restrained by anti-apoptotic Bcl-2 family proteins in healthy liver.
    Kodama T; Hikita H; Kawaguchi T; Saito Y; Tanaka S; Shigekawa M; Shimizu S; Li W; Miyagi T; Kanto T; Hiramatsu N; Tatsumi T; Takehara T
    J Biol Chem; 2013 Oct; 288(42):30009-30018. PubMed ID: 23986435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak.
    Uren RT; Dewson G; Chen L; Coyne SC; Huang DC; Adams JM; Kluck RM
    J Cell Biol; 2007 Apr; 177(2):277-87. PubMed ID: 17452531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response.
    Sarosiek KA; Chi X; Bachman JA; Sims JJ; Montero J; Patel L; Flanagan A; Andrews DW; Sorger P; Letai A
    Mol Cell; 2013 Sep; 51(6):751-65. PubMed ID: 24074954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins.
    Chipuk JE; Fisher JC; Dillon CP; Kriwacki RW; Kuwana T; Green DR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20327-32. PubMed ID: 19074266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets.
    Kodama T; Takehara T; Hikita H; Shimizu S; Shigekawa M; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Yin XM; Hayashi N
    J Biol Chem; 2011 Apr; 286(16):13905-13. PubMed ID: 21367852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
    Gillespie S; Borrow J; Zhang XD; Hersey P
    Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of Bax bound to the BH3 peptide of Bim identifies important contacts for interaction.
    Robin AY; Krishna Kumar K; Westphal D; Wardak AZ; Thompson GV; Dewson G; Colman PM; Czabotar PE
    Cell Death Dis; 2015 Jul; 6(7):e1809. PubMed ID: 26158515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis.
    Clohessy JG; Zhuang J; de Boer J; Gil-Gómez G; Brady HJ
    J Biol Chem; 2006 Mar; 281(9):5750-9. PubMed ID: 16380381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins.
    Werneburg NW; Guicciardi ME; Bronk SF; Kaufmann SH; Gores GJ
    J Biol Chem; 2007 Sep; 282(39):28960-28970. PubMed ID: 17686764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptides from human BNIP5 and PXT1 and non-native binders of pro-apoptotic BAK can directly activate or inhibit BAK-mediated membrane permeabilization.
    Aguilar F; Yu S; Grant RA; Swanson S; Ghose D; Su BG; Sarosiek KA; Keating AE
    Structure; 2023 Mar; 31(3):265-281.e7. PubMed ID: 36706751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.